Pectoral Nerves Block to Relieve Post-sternotomy Pain After Cardiac Surgery

• Status: Not yet recruiting
• Trial end date: 2022-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this study is to determine if the addition of PECS2 block provides superior post-operative analgesia for cardiac surgery patients after midline sternotomy compared to only standard-of-care post-operative pain medication.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: NYU Langone Health
• Treatments: Dexmedetomidine; Epinephrine; Epinephryl borate; Lidocaine; Racepinephrine; Ropivacaine

Criteria

Inclusion Criteria:

1. Obtaining one or more of the following elective surgical procedures at NYU Winthrop Hospital with midline sternotomy:

• Coronary artery bypass graft (any number of vessels)

• Aortic Valve Replacement (AVR)

• Aortic Valve Repair

• Mitral Valve Replacement (MVR)

• Mitral Valve Repair

• Tricuspid Valve Replacement

• Tricuspid Valve Repair

• Pulmonic Valve replacement

• Pulmonic Valve Repair

• Congenital Heart Defect Repair

• Ascending Thoracic Aortic Aneurism Repair

• Patient Age > 18 years.

2. Willingness and ability to participate in the study procedures

3. Sufficiently hemodynamically stable to give consent

Exclusion Criteria:

An individual who meets any of the following criteria will be excluded from participation in this study:

• Hemodynamic instability

• Preexisting infection at site of block

• Allergy to block agents

• Severe psychiatric illness

• Intubated emergently prior to reception by the perioperative team

• Patient is preoperatively on extracorporeal membrane oxygenation (ECMO) treatment.

• Pregnant patient

• Recent surgery